Clinical Trial Update: Telitacicept in Primary APS Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of telitacicept in primary antiphospholipid syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Telitacicept

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Anti Phospholipid Syndrome | Phase 2 | Status: TERMINATED